Literature DB >> 26408880

Apoptosis-inducing effects of lentinan on the proliferation of human bladder cancer T24 cells.

Lidao Bao1, Yi Wang1, Ruilian Ma1, Xianhua Ren1, Rui Cheng1, Agula B2.   

Abstract

The aim of this study was to explore the effects of lentinan on the proliferation of human bladder cancer T24 cells and the mechanism regarding the inhibition of cell growth. When gene regulation technique was used to build pcDNA3-TRPM8 expression plasmid, TRPM8 channel activator-lentinan was used for intervention to observe the proliferation of T24 cells. Flow cytometry cell screening method was used to observe the cell ratio of each cell cycle of T24 cells and the ratio of apoptotic and dying cells under the intervention of different concentrations of lentinan using PI single-staining and Annexin V-FITC/PI double-staining. JC-1 and DCFH-DA fluorescence probes were used to observe the influence of different concentrations of lentinan on the mitochondrial membrane potential of T24 cells and intracellular reactive oxygen species (ROS) by confocal microscope. pcDNA-TRPM8 plasmid was successfully constructed, and lentinan could inhibit the growth of T24 cells in a dose-dependent pattern. Lentinan played its biological effect through TRPM8 channel to further inhibit the growth of T24 cells, reduced the mitochondrial membrane potential of bladder cancer T24 cell line, and increased the generation of ROS in human bladder cancer T24 cell line. Lentinan led to mitochondrial depolarization or activation of non-mitochondrial pathway to induce intracellular ROS generation, thus eventually inducing T24 cell death and growth inhibition.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26408880

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  5 in total

Review 1.  Lentinan as an immunotherapeutic for treating lung cancer: a review of 12 years clinical studies in China.

Authors:  Yiran Zhang; Meng Zhang; Yifei Jiang; Xiulian Li; Yanli He; Pengjiao Zeng; Zhihua Guo; Yajing Chang; Heng Luo; Yong Liu; Cui Hao; Hua Wang; Guoqing Zhang; Lijuan Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-24       Impact factor: 4.553

2.  Lentinan triggers oxidative stress-mediated anti-inflammatory responses in lung cancer cells.

Authors:  Mo Li; Xin Du; Zheng Yuan; Mengzhi Cheng; Penghua Dong; Yu Bai
Journal:  Mol Cell Biochem       Date:  2021-11-16       Impact factor: 3.396

3.  Phenylalanine-Derived β-Lactam TRPM8 Modulators. Configuration Effect on the Antagonist Activity.

Authors:  María Ángeles Bonache; Pedro Juan Llabrés; Cristina Martín-Escura; Roberto De la Torre-Martínez; Alicia Medina-Peris; Laura Butrón; Isabel Gómez-Monterrey; Ana María Roa; Gregorio Fernández-Ballester; Antonio Ferrer-Montiel; Asia Fernández-Carvajal; Rosario González-Muñiz
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

4.  Lentinan Inhibits Tumor Progression by Immunomodulation in a Mouse Model of Bladder Cancer.

Authors:  Ming Sun; Renge Bu; Bin Zhang; Yaming Cao; Chengyang Liu; Wenyan Zhao
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

5.  Highly functionalized β-lactams and 2-ketopiperazines as TRPM8 antagonists with antiallodynic activity.

Authors:  M Ángeles Bonache; Cristina Martín-Escura; Roberto de la Torre Martínez; Alicia Medina; Sara González-Rodríguez; Andrés Francesch; Carmen Cuevas; Ana María Roa; Gregorio Fernández-Ballester; Antonio Ferrer-Montiel; Asia Fernández-Carvajal; Rosario González-Muñiz
Journal:  Sci Rep       Date:  2020-08-25       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.